… inhaled corticosteroids (ICS) is common in patients with chronic obstructive pulmonary disease
(COPD) and has been associated with an increased risk … if ICS increases the risk of lower …

… cumulative dose of inhaled corticosteroids is inversely related … and little or no exposure
to oral corticosteroids (2). A similar … risk associated with the use of inhaled corticosteroids is …

Aims The association between inhaled corticosteroid ( ICS ) use and pulmonary tuberculosis
( TB ) development is uncertain. We conducted a population‐based case–control study to …

… well as other conditions associated with the risk of fracture (32). We quantified the severity
of respiratory disease, independently of inhaled corticosteroid use, by counting the number of …

Background The widespread use of inhaled corticosteroids (ICSs) for COPD treatment has
been questioned. Recent studies of weaning some patients with COPD off ICSs found little or …

… risk is. Because there are no placebo-controlled trials large enough to determine whether
inhaled corticosteroids … is seen with inhaled corticosteroid use, although the risk is smaller and …

… Understanding of the mechanisms of increased pneumonia risk with inhaled corticosteroids
is urgently needed to clarify their role in the management of COPD and to aid the …

… 44 Singh S, Amin AV, Loke YK: Long-term use of inhaled corticosteroids and the risk of
pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med 2009; 169…

… with inhaled corticosteroids (ICS). However, the impact of ICS use on fracture risk remains
… -up was not associated with an increased fracture risk (adjusted odds ratio = 0.97; 95% …

… Inhaled corticosteroids (ICSs) are often prescribed in patients with chronic obstructive
pulmonary disease (COPD). Their impact on the risk of … Inhaled corticosteroids and risk of lung …